Earnings History Data for Acasti Pharma, Inc. (ACST) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Acasti Pharma, Inc.

Acasti Pharma Inc. is a biopharmaceutical company. It is focused on research, development and commercialization of krill oil based forms of omega-3 phospholipid therapies. CaPre (R), Acasti's only prescription drug candidate, is being developed to help prevent and treat hypertriglyceridemia. ONEMIA (R) is a medical food and currently Acasti's only commercialized product. Acasti Pharma Inc. is headquartered in Laval, Canada.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
14-02-2022 PM 7:00 AM ET
(Feb 14)
ACST Acasti Pharma, Inc. 54.47 -0.09 -0.08 -0.16 Acasti Pharma GAAP EPS of -$0.09 misses by $0.01
[2/14/2022 7:00 AM]
1.21 0.07 
1.18 0.04 
1.04 - 9.12 176,215 240,000 14,484
10-11-2021 PM 6:55 AM ET
(Nov 10)
ACST Acasti Pharma, Inc. 75.29 0.03 0.00 -0.40 Acasti Pharma EPS beats by $0.60
[11/10/2021 7:20 AM]
1.66 -0.03 
1.73 0.04 
1.47 - 9.76 361,192 380,000 23,682